Anaheim, CA, Oct. 26, 2017 (GLOBE NEWSWIRE) -- LiveWire Ergogenics, Inc. (OTC: LVVV) a company focused on the acquisition and build-out of turnkey properties, product development and research partnerships for the commercialization of legal cannabinoid-based products, announced today that it has executed a lease on 4-acres of property in a commercial agriculture zoned region of Southern California, completed set-up of the Company’s greenhouse and readies for production.
“Greenhouse-number-one will be operated by the horticulture experts at The Greenhouse Collect, a non-profit organization serving medical marijuana patients since 2014. They will lease the facility from LiveWire to operate their medical cannabis clone development project,” said Bill Hodson, CEO of LiveWire Ergogenics. “The turnkey greenhouse was purchased from GreenGro Technologies, Inc.’s (OTC: GRNH) line of state-of-the-art, fully automated Greenhouses. For examples please visit https://greengrotech.com/automated-light-deprivation-greenhouses/
The property is located in Southern California and is large enough to host five, large and fully functional greenhouses. This four-acre location will serve as LiveWire’s flagship project, according to its master plan to establish a secure, campus-like setting for every LiveWire location populated with multiple greenhouses and research facilities. This first commercial agriculture zoned property also includes a 2,000-square foot residence that is home to the LiveWire caretaker and security team that manages and supervises the property 24/7.
LiveWire has started the required licensing and compliance process for this location and is in the process of applying for a Type-4 Cultivation / Nursery and live-plant transport license on behalf of the Greenhouse Collect. LiveWire currently does not grow, harvest or distribute marijuana that violates any local, state or federal laws.
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. (LVVV) is focused on identifying and monetizing current and future trends in the health and wellness industry. The Company is focused on acquiring, building out and leasing turnkey operation properties for lease to qualified clients and establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with a large “sufferer” population for human and veterinarian applications. This includes the legal cloning of cannabis Strains for research purposes, with the goal to produce positive medicinal results, establish a quality control and dosing verification system of zero pesticide products for quality brands and the development and licensing of a range of high-quality cannabinoid based products and services. The LiveWire Ergogenics team and its consulting experts have long standing experience in the sector, a passion for cannabis research and is committed to generate and implement innovative ideas to produce high-quality products that satisfy an increasing demand in this fast-growing industry. LiveWire’s strategy includes acquiring, building out and leasing turnkey properties, selling location specific compliance packages and offering financing solutions for select candidates in the cannabis industry. The LiveWire management team and experts will guide its clients into a legal, profitable and sustainable business, by assisting in crafting business plans, design revenue models and provide compliance notifications.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial prohjections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals a nd commercialization of the Company’s products, or any of the Company’s other proposed products, systems or services. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and actual events may differ considerably. Factors that may cause actual results to differ materially from any projections may include, without limitation, the Company’s inability to obtain additional financing, delays in the development of its products, the impact of significant government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.